Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

92.88
-2.2200-2.33%
Post-market: 92.80-0.0800-0.09%19:44 EDT
Volume:644.33K
Turnover:60.29M
Market Cap:8.09B
PE:-15.70
High:95.82
Open:95.82
Low:92.58
Close:95.10
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:75.47M
Volume Ratio:0.47
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.9176
EPS(LYR):-5.6758
ROE:-252.35%
ROA:-62.88%
PB:19.61
PE(LYR):-16.36

Loading ...

Movement Alert|Abivax S.A. Falls 5.33% in Regular Trading, Upcoming Earnings Forecast Points to Over 40% Revenue Decline

Market Focus
·
Sep 15

Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
·
Sep 14

Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish

Earnings Agent
·
Sep 14

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

Abivax Sa: Shares up 2.8% After Gs Initiates at 'Buy'

THOMSON REUTERS
·
Sep 10

Abivax Sa : Goldman Sachs Initiates Coverage with Buy Rating

THOMSON REUTERS
·
Sep 10

Abivax initiated with a Buy at Goldman Sachs

TIPRANKS
·
Sep 10

Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod

THOMSON REUTERS
·
Jul 31

Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026

THOMSON REUTERS
·
Jul 31

Movement Alert|Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180

Market Focus
·
Jul 30

Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says

MT Newswires Live
·
Jul 24

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating

MT Newswires Live
·
Jul 24

Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up

Reuters
·
Jul 24

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

TIPRANKS
·
Jul 18

Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies

MT Newswires Live
·
Jul 16

Abivax price target raised to $175 from $165 at Piper Sandler

TIPRANKS
·
Jul 09

Abivax Closes $920 Million ADS Offering

MT Newswires Live
·
Jul 07

Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says

MT Newswires Live
·
Jul 06

Abivax Sa : Wedbush Raises Target Price to $140 from $110

THOMSON REUTERS
·
Jul 06

Wedbush Raises Price Target on Abivax to $140 From $110, Keeps Neutral Rating

MT Newswires Live
·
Jul 06